Impact of the COVID-19 Pandemic on Pediatric Cystic Fibrosis Pulmonary Exacerbations
| dc.contributor.author | Patel, Shreya | |
| dc.contributor.author | Thompson, Misty | |
| dc.contributor.author | Slaven, James | |
| dc.contributor.author | Sanders, Don | |
| dc.contributor.author | Ren, Clement | |
| dc.contributor.department | Pediatrics, School of Medicine | en_US |
| dc.date.accessioned | 2021-04-02T20:50:14Z | |
| dc.date.available | 2021-04-02T20:50:14Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | To assess the impact of COVID-19 restrictions on cystic fibrosis (CF) pulmonary exacerbations (PEx) we performed a retrospective review of PEx events at our CF Center and compared the rate of PEx in 2019 vs 2020. Restrictions on social interaction due to the COVID-19 pandemic were associated with a lower rate of PEx at our pediatric CF Center, suggesting that these restrictions also reduced exposure to other respiratory viral infection in children with CF. | en_US |
| dc.identifier.citation | Patel, S., Thompson, M., Slaven, J., Sanders, D., & Ren, C. (2020). Impact of the COVID-19 Pandemic on Pediatric Cystic Fibrosis Pulmonary Exacerbations. Authorea Preprints. https://doi.org/10.22541/au.160491826.69450223/v1 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/25540 | |
| dc.language.iso | en | en_US |
| dc.relation.isversionof | 10.22541/au.160491826.69450223/v1 | en_US |
| dc.relation.journal | Authorea Preprints | en_US |
| dc.source | Other | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | cystic fibrosis | en_US |
| dc.subject | CF pulmonary exacerbations | en_US |
| dc.title | Impact of the COVID-19 Pandemic on Pediatric Cystic Fibrosis Pulmonary Exacerbations | en_US |
| dc.type | Preprint | en_US |